No FDA Warning Letters For Device Firms Participating In IMDRF Single-Audit Pilot
This article was originally published in The Silver Sheet
Executive Summary
Online-Only Content >>> Warning letters will not be issued to manufacturers that volunteer to be inspected under the International Medical Device Regulators Forum’s single-audit pilot program unless a significant threat to public health is uncovered, CDRH official Kim Trautman says.